# Andrea Ardizzoni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrea-ardizzoni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,694 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 70 |
| i10-index | 325 |
| Last Known Institution | Azienda USL di Bologna |
| OpenAlex ID | https://openalex.org/A5032386417 |
| ORCID iD | https://orcid.org/0000-0003-2678-0714 |
| Works | 791 |

## Researcher papers

- [Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-erlotinib-in-patients-with-untreated-egfr-mutated-advanced-non/)
- [Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis](https://scholariq.org/papers/cisplatin-versus-carboplatin-based-chemotherapy-in-first-line-treatment-of/)
- [Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/small-cell-lung-cancer-esmo-clinical-practice-guidelines-for-diagnosis-treatment/)
- [Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value](https://scholariq.org/papers/low-pd-1-expression-in-cytotoxic-cd8-tumor-infiltrating-lymphocytes-confers-an/)
- [Grading the neuroendocrine tumors of the lung: an evidence-based proposal](https://scholariq.org/papers/grading-the-neuroendocrine-tumors-of-the-lung-an-evidence-based-proposal/)
- [First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status](https://scholariq.org/papers/first-line-pembrolizumab-in-advanced-non-small-cell-lung-cancer-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Azienda USL di Bologna](https://scholariq.org/institutions/azienda-usl-di-bologna/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.